While Boston tends to get the lion’s share of recognition as the premier biopharma hub on the East Coast of the United States, other cities and states are looking to make their names known as a strong location for the industry. New Jersey, New York and New Hampshire have gone to great lengths to distinguish themselves, but so too has smaller Rhode Island.
EVERSANA announced the appointment of Bhaskar Sambasivan to President, Patient Services and Chief Strategy Officer.
Mid-year doldrums are hitting as multiple pharmaceutical and biotech companies have initiated layoffs across the United States.
Nearly 12 million people had their financial, medical and personal information exposed due to a Quest Diagnostics data breach.
EVERSANA, a leading independent provider of commercial services to the life science industry, announced the acquisition of Alamo Pharma Services Inc. and BexR Logistix LLC Telesales from Mission Pharmacal Company.
EVERSANA doubles cold chain storage capabilities to serve transformative life science therapy advancements
EVERSANA, the leading independent provider of global services to the life science industry, announced that expansions to the company’ cold chain storage capabilities are complete and ready to meet the growing 3PL and complex channel distribution needs of the pharmaceutical industry.
There is something of a recurring theme among the life science, healthcare and biopharma industries: a shortage of skilled employees will lead to a decrease in innovation.
Life science incubators and accelerators play a highly significant role in the industry and may be the key for regional growth, a new report shows.
Charles River Laboratories and Janssen Pharmaceutical are both making cuts as they reprioritize their businesses, according to Worker Adjustment and Retraining Notifications filed with the state of California.